Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.5 INR | +3.81% | +3.81% | -5.50% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 1,082 | 473 | 82.45 | 161.1 | 319.6 | 352.2 |
Enterprise Value (EV) 1 | 1,171 | 676.9 | 272.6 | 385.7 | 555.7 | 613.5 |
P/E ratio | 60.9 x | 763 x | -0.84 x | -5.83 x | -3.32 x | 30.7 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 4.18 x | 1.45 x | 0.29 x | 0.6 x | 1.47 x | 0.79 x |
EV / Revenue | 4.52 x | 2.07 x | 0.95 x | 1.45 x | 2.55 x | 1.38 x |
EV / EBITDA | 28.9 x | 26.5 x | -3.12 x | -73.6 x | -8.3 x | 17.1 x |
EV / FCF | 131 x | -5.75 x | 14.6 x | -12 x | 27.2 x | -18.9 x |
FCF Yield | 0.77% | -17.4% | 6.83% | -8.33% | 3.67% | -5.28% |
Price to Book | 3.95 x | 1.72 x | 0.47 x | 1.08 x | 6.05 x | 5.48 x |
Nbr of stocks (in thousands) | 12,783 | 12,783 | 12,783 | 12,783 | 12,783 | 12,783 |
Reference price 2 | 84.65 | 37.00 | 6.450 | 12.60 | 25.00 | 27.55 |
Announcement Date | 5/30/18 | 9/9/19 | 9/4/20 | 9/6/21 | 9/8/22 | 9/14/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 258.8 | 326.7 | 287 | 266.6 | 217.8 | 443.4 |
EBITDA 1 | 40.49 | 25.51 | -87.26 | -5.241 | -66.95 | 35.96 |
EBIT 1 | 28.2 | 9.654 | -104.4 | -22.93 | -84.64 | 18.27 |
Operating Margin | 10.89% | 2.95% | -36.37% | -8.6% | -38.86% | 4.12% |
Earnings before Tax (EBT) 1 | 21.7 | 0.5289 | -119.8 | -25.91 | -96.08 | 11.47 |
Net income 1 | 17.66 | 0.62 | -98.39 | -27.6 | -96.08 | 11.47 |
Net margin | 6.82% | 0.19% | -34.28% | -10.35% | -44.12% | 2.59% |
EPS 2 | 1.390 | 0.0485 | -7.700 | -2.160 | -7.520 | 0.8974 |
Free Cash Flow 1 | 8.959 | -117.7 | 18.61 | -32.12 | 20.42 | -32.39 |
FCF margin | 3.46% | -36.03% | 6.49% | -12.05% | 9.37% | -7.31% |
FCF Conversion (EBITDA) | 22.12% | - | - | - | - | - |
FCF Conversion (Net income) | 50.73% | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 5/30/18 | 9/9/19 | 9/4/20 | 9/6/21 | 9/8/22 | 9/14/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 88.5 | 204 | 190 | 225 | 236 | 261 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 2.185 x | 7.995 x | -2.179 x | -42.87 x | -3.527 x | 7.267 x |
Free Cash Flow 1 | 8.96 | -118 | 18.6 | -32.1 | 20.4 | -32.4 |
ROE (net income / shareholders' equity) | 6.94% | 0.23% | -43.6% | -17% | -95.3% | 19.6% |
ROA (Net income/ Total Assets) | 3.92% | 1.18% | -12% | -2.91% | -11.9% | 2.59% |
Assets 1 | 450.7 | 52.39 | 822.3 | 948.7 | 806.9 | 442.6 |
Book Value Per Share 2 | 21.50 | 21.50 | 13.80 | 11.60 | 4.130 | 5.030 |
Cash Flow per Share 2 | 0.6300 | 0.4500 | 0.5100 | 0.7700 | 0.6300 | 0.6300 |
Capex 1 | 54.9 | 84.5 | 17.9 | 1.08 | 9.05 | 7.59 |
Capex / Sales | 21.2% | 25.87% | 6.25% | 0.4% | 4.15% | 1.71% |
Announcement Date | 5/30/18 | 9/9/19 | 9/4/20 | 9/6/21 | 9/8/22 | 9/14/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-5.50% | 6.06M | |
+5.41% | 106B | |
-4.31% | 64.74B | |
+73.33% | 49.34B | |
+17.24% | 39.15B | |
+6.13% | 32.86B | |
+12.77% | 20.29B | |
+15.03% | 17.21B | |
+19.06% | 15.28B | |
+6.28% | 14.58B |
- Stock Market
- Equities
- VSCL Stock
- Financials Vadivarhe Speciality Chemicals Limited